The Biostatistics Core Resource is a shared resource organized to meet the needs of the USC/Norris Comprehensive Cancer Center in the areas of study design, data management, study monitoring, and data analysis. Core statisticians provide this support to Cancer Center investigators conducting cancer-related research involving molecular genetics, cell biology, developmental therapeutics and clinical trials, cancer epidemiology, and cancer control research, with particular emphasis in the translational research programs which focus on genitourinary cancers, gastrointestinal cancers, breast cancer, and hematological malignancies and retroviral diseases. The specific objectives are: 1. To provide statistical at the USC/Norris Comprehensive Cancer Center (USC/NCC) during the planning, conduct, and analysis of cancer research studies. 2. To work with members of the Clinical Investigations Support Office (CISO) in the planning, monitoring, and analysis of clinical trials approved by the Clinical Investigations Committee (CIC). 3. To work with members of the Cancer Research Informatics Core (CRIC) Facility, the Translational Pathology Core Facility, and the Microarray Core Facility to support the completion of translational studies by identifying required specimens, maintaining disease-specific databases with clinical outcome information, and efficiently merging complex gene expression data with relevant clinical information. 4. To adapt and incorporate , or when appropriate to develop, innovations in statistical and clinical trials methodology into the design and analysis of cancer research studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014089-26
Application #
6443825
Study Section
Project Start
1980-04-01
Project End
2005-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
$91,598
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Miller, Kimberly A; Ramirez, Cynthia N; Wojcik, Katherine Y et al. (2018) Prevalence and correlates of health information-seeking among Hispanic and non-Hispanic childhood cancer survivors. Support Care Cancer 26:1305-1313
Liu, Minmin; Zhang, Lian; Li, Hongtao et al. (2018) Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma. Hepatology 68:1412-1428
Tobin, Jessica; Allem, Jon-Patrick; Slaughter, Rhona et al. (2018) Posttraumatic growth among childhood cancer survivors: Associations with ethnicity, acculturation, and religious service attendance. J Psychosoc Oncol 36:175-188
Belic, Jelena; Graf, Ricarda; Bauernhofer, Thomas et al. (2018) Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. Int J Cancer 143:1236-1248
Iriondo, Oihana; Liu, Yarong; Lee, Grace et al. (2018) TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun 9:1994
Schaal, Justin B; Maretzky, Thorsten; Tran, Dat Q et al. (2018) Macrocyclic ?-defensins suppress tumor necrosis factor-? (TNF-?) shedding by inhibition of TNF-?-converting enzyme. J Biol Chem 293:2725-2734
Robison, Nathan J; Yeo, Kee Kiat; Berliner, Adrian P et al. (2018) Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol 138:199-207
Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine et al. (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15-22
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472

Showing the most recent 10 out of 842 publications